Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2010
05/20/2010WO2010034019A4 Transdermal drug delivery using an osmolyte and vasoactive agent
05/20/2010WO2010018217A3 Purin derivatives for use in the treatment of fab-related diseases
05/20/2010WO2010017369A3 Macromolecular diffusion and release from self-assembled b-hairpin peptide hydrogels
05/20/2010WO2010011466A3 Controlled-release cns modulating compositions and methods for the treatment of otic disorders
05/20/2010WO2010010555A3 Transdermal system for extended delivery of incretins and incretin mimetic peptides
05/20/2010WO2010004287A3 Process for preparing microparticles
05/20/2010WO2009152084A3 Adipose tissue-derived stem cells for veterinary use
05/20/2010WO2009125117A3 Dermatological composition that can be used in particular for the care and prevention of eschars
05/20/2010WO2009097672A3 Pharmaceutical composition, dressing and method for treating skin lesion, intermediate composition and process for preparing said dressing, and use of cerium salt associated with a collagen matrix
05/20/2010WO2009091576A3 Parenteral formulations of dopamine agonists
05/20/2010WO2009040818A9 Compositions comprising lipophilic active compounds and method for their preparation
05/20/2010WO2009033588A3 Self-controlled insulin delivery system
05/20/2010US20100125101 Immunostimulatory nucleic acid molecules
05/20/2010US20100125070 Bupropion Metabolites and Methods of Their Synthesis and Use
05/20/2010US20100125057 Topical skin care composition
05/20/2010US20100124572 Magnetic microsphere and method of forming a microsphere
05/20/2010US20100124571 Use of pH-sensitive, Acid-Stable Metal-Binding Nanoparticles
05/20/2010US20100124570 Highly resilient copolymer with shape recovery force and flexibility and the use thereof for the repair of articular cartilage defects
05/20/2010US20100124569 Amnion derived adherent cells
05/20/2010US20100124568 Pharmaceutical articles coated with lubricious coatings
05/20/2010US20100124567 Stabilizing alkylglycoside compositions and methods thereof
05/20/2010US20100124566 Protection against and treatment of ionizing radiation
05/20/2010US20100124565 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010US20100124560 Multi portion intra-oral dosage form and use thereof
05/20/2010US20100124537 Medical applications of alpha-ketoglutarate
05/20/2010US20100124536 Hemophilia Treatment by Inhalation of Coagulation Factors
05/20/2010US20100124535 Aerosol Dispersions of Particles with Active Pharmaceutical Ingredients
05/20/2010US20100122918 Ophthalmic and contact lens solution
05/20/2010DE102008057186A1 Producing mineralized protein hollow body encapsulated with biological and chemical material comprises dissolving primarily produced capsules after protein coating and enzymatic crosslinking and stabilizing remaining protein hollow body
05/20/2010DE102008043724A1 Erhöhung der Effizienz pharmazeutische Wirkstoffe-freisetzender Medizinprodukte durch Kombination mit einem Inhibitor des Transportproteins P-Glycoprotein Increasing the efficiency of active pharmaceutical ingredients eluting medical devices by combination with an inhibitor of the transport protein P-glycoprotein
05/20/2010CA2743901A1 Transdermal systems containing multilayer adhesive matrices to modify drug delivery
05/20/2010CA2743837A1 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010CA2743639A1 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010CA2743615A1 Compositions and methods for alleviating hyposalivation and for providing oral comfort
05/20/2010CA2743600A1 Method for preparing microspheres and microspheres produced thereby
05/20/2010CA2743491A1 Inhibition of mammalian target of rapamycin
05/20/2010CA2743469A1 Antibody formulation
05/20/2010CA2743006A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010CA2742846A1 Releasable fusogenic lipids for nucleic acids delivery systems
05/20/2010CA2742449A1 Improved dissolution stability of calcium carbonate tablets
05/19/2010EP2186835A1 Tenside-free cosmetic, dermatological and pharmaceutical medium.
05/19/2010EP2186789A1 Method of producing reduced coenzyme q10 and method of stabilizing the same
05/19/2010EP2186512A1 Use of allylcysteine or its analogs and pharmaceutical composition threrof
05/19/2010EP2186510A2 Matrix compositions for controlled delivery of drug substances
05/19/2010EP2186509A2 Propofol transparent anaesthetic solution with low venous irritation
05/19/2010EP2186508A2 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
05/19/2010EP2186507A2 A liquid pharmaceutical formulation comprising nicotine for the administration to the oral cavity
05/19/2010EP2185637A1 Biocompatible foams, systems, and methods
05/19/2010EP2185161A2 Silica-based nanoparticles and methods of stimulating bone formation and suppressing bone resorption through modulation of nf-kb
05/19/2010EP2185157A1 Dhea compositions for treating menopause
05/19/2010EP2185147A1 Intranasal pharmaceutical compositions comprising succinic acid and methods thereof
05/19/2010EP2185146A1 Pharmaceutical compositions for intranasal administration comprising choline salts of succinic acid
05/19/2010EP2185139A2 Bupropion hydrobromide and therapeutic applications
05/19/2010EP2185137A1 Carrier-free orodispersible and/or dispersible solid composition with noticeable effect and method for preparing same
05/19/2010EP2185136A2 Oral calcitonin compositions and applications thereof
05/19/2010EP2185134A2 Device for the oral administration of active principles
05/19/2010EP2185132A1 Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
05/19/2010EP2185131A2 Continuous process for microspheres production by using expanded fluids
05/19/2010EP2185130A2 Tablet containing donepezile hydrochloride in amorphous form
05/19/2010EP2185129A1 Pellet for animals and method for its production
05/19/2010EP1727865B1 Particle-stabilised emulsions
05/19/2010EP1699441B1 Method of manufacture of fast-disintegrating tablets
05/19/2010EP1653815B1 Methods for reducing astringency
05/19/2010EP1463487B1 Liposomal delivery of vitamin e based compounds
05/19/2010EP1435994B1 Novel use of pulmonary surfactant
05/19/2010EP1392242B1 Method of forming an aerosol for inhalation delivery
05/19/2010EP1343510B1 Light stabilized antimicrobial materials
05/19/2010EP1214097B9 Nucleic acids encoding polyepitope polypeptides
05/19/2010EP1115382B1 Immunogenic liposome compositions
05/19/2010CN201469700U Wind-dispelling rod adopting sulphur as main raw materials
05/19/2010CN201469699U Modified plant starch hollow capsule for medicine and food
05/19/2010CN1994425B Soft capsule of 'Sheng Mai' and preparation method thereof
05/19/2010CN1994420B Blood-clearing face-beautifying health product and preparation method thereof
05/19/2010CN1985916B Anaer vagina cleaning effervescent tablet and its production process
05/19/2010CN1981836B Stasis-expelling drop pills for treating coronary heart disease, angina cordis and high blood fat and thereof making method
05/19/2010CN1973901B Composite microsphere preparation of lactic acid-hydroxyacetic acid copolymer and its preparation process
05/19/2010CN1961934B Method for preparing Chinese medicinal wine for treating humerus lateral epicondylitis
05/19/2010CN1957920B Anti cancer slow release agent carrying fluorouracil and synergist
05/19/2010CN1939515B Abstinence Chinese-medicinal preparation and its making method
05/19/2010CN1939343B Bone-peptide sodium chloride injection and its making method
05/19/2010CN1927363B Health food, its preparation method and application
05/19/2010CN1927309B Traditional Chinese medicine composition detection method
05/19/2010CN1927257B Traditional Chinese medicine for treating osteoporosis and its preparation method
05/19/2010CN1927185B Maleic acid trimebutine slow release tablet comprising quick release part and preparing method thereof
05/19/2010CN1927175B Compound recipe anticancer slow release injection comprising tetrazole violet
05/19/2010CN1923173B Anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof
05/19/2010CN1923171B Compound recipe anti-cancer drugs slow release agent comprising anticancer antibiotics and synergist thereof
05/19/2010CN1919174B Anticancer slow release agent including nimustine and its synergist
05/19/2010CN1879688B Preparation for treating wind-heat type cold, its preparation process and quality control method
05/19/2010CN1875936B Anticancer sustained release agent containing clorfarabine and cytotoxic drug
05/19/2010CN1857227B Supercritical fluid aided double circulation process for carrying medicine onto polymer microballoon
05/19/2010CN1631385B Ointment for treating burn and scald and its preparing process
05/19/2010CN101711255A Modified globin proteins with altered electron transport pathway
05/19/2010CN101711174A Controlled release oral formulations of ion channel modulating compounds and related methods for preventing arrhythmia
05/19/2010CN101709073A Nucleotide phospholipid molecule and lipidosome and preparation method and application thereof
05/19/2010CN101709042A Aseptic arginine glutamate and preparation method of powder injection thereof
05/19/2010CN101708339A Nano floxuridine/stratiform thermometal hydroxide hybrid and preparation method thereof
05/19/2010CN101708338A Prodrug containing sterides structures and high dispersion preparation thereof
05/19/2010CN101708337A Preparation method of human serum albumin nano granules coated with oxaliplatin
05/19/2010CN101708336A Novel medicinal premixing auxiliary material